TrialBMJ open2014

Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocol.

Christian Anholm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.